Skip to main content
. 2024 Sep 12;9(12):3439–3445. doi: 10.1016/j.ekir.2024.08.033

Figure 2.

Figure 2

Percentage decrease of PLA2Rab during treatment (baseline titer is plotted as 100%). Patients in the highest tertile of PLA2Rab are depicted in red. PLA2Rab half-life is more than 7 days in 5 of 9 patients in the highest tertile (identifiable by PLA2Rab levels > 25% after 2 weeks or > 6.25% after 4 weeks, respectively).